The South Korea Biosurgery Market was valued at $272.2 Million in 2025 and projected to reach to $369.1 Million by 2030, representing a compound annual growth rate of 6.3%. South Korea's biosurgery market is positioned for sustained growth through 2030, driven by an aging population requiring increased surgical interventions and rising healthcare expenditure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea's biosurgery market is valued at USD 272.2 million in 2025, with projected growth to USD 369.1 million by 2030, representing a steady CAGR of 6.3%.
South Korea's state-of-the-art medical facilities and high surgical volumes create a robust demand environment for innovative biosurgical products and solutions.
Strong adoption of minimally invasive surgical techniques across South Korean hospitals drives increased utilization of biosurgical hemostats, sealants, and adhesion barriers.
South Korea's progressive regulatory framework and rapid approval pathways for medical devices facilitate faster market entry and commercialization of biosurgical innovations.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | BONE MORPHOGENETIC PROTEINS (Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 6.4% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 15.83 (2025) |
| Revenue Forecast (Billions) | ~USD 21.59 (2030) |
| Segments Covered | Type, Origin, Application, End User, Product |
5 segment dimensions are covered across the global market.
South Korea's biosurgery market is valued at USD 272.2 million in 2025.
South Korea's biosurgery market is projected to reach USD 369.1 million by 2030.
South Korea's biosurgery market is growing at a CAGR of 6.3% from 2025 to 2030.
South Korea's market growth is driven by advanced healthcare infrastructure, an aging population, rising chronic disease prevalence, and strong adoption of minimally invasive surgical techniques.
South Korea is a leading biosurgery market in Asia Pacific, supported by robust regulatory frameworks, significant R&D investment, and favorable reimbursement policies that enhance market competitiveness.
The study involved major activities in estimating the current market size for the biosurgery market. Exhaustive secondary research was done to collect information on the biosurgery industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Biosurgery market.
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources [such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global biosurgery market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the biosurgery market. The primary sources from the demand side include ambulatory surgical centers, hospitals, Clinics, and other end users. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
A breakdown of the primary respondents is provided below:
*C-level primaries include CEOs, CFOs, COOs, and VPs.
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global biosurgery market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global biosurgery market was split into various segments and sub-segments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the global biosurgery market's overall size through the methodology mentioned above, this market was split into several segments and subsegments. Where applicable, the data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Biosurgery products are essential in surgical procedures, aiding in the repair of damaged tissues and bones. Surgeons utilize these products to stabilize skin, internal organs, and blood vessels, ensuring hemostasis and tissue integrity after injury or surgery. Key types include surgical sealants, hemostatic agents, adhesion barriers, soft-tissue attachments, bone-graft substitutes, and staple-line reinforcement agents, all designed to enhance healing and prevent complications.
Full forecast, segment splits, and company analysis for all Biosurgery Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report